Long-Term Care

Happy Residents, Better Results

Skilled nursing facilities, assisted living, and other long-term care organizations benefit from genetics-based medication management for their residents, families, and care teams.

The Med Management “Guessing Game” is Challenging for Any Long-Term Care Facility

34.5%

of older patients with schizophrenia utilize long-term care facilities1

(resulting in 39% higher direct costs than other LTC residents)

$19k

Cost per hospital visit resulting from a non-fatal falls among older adults3

(est. $1,112 per ED visit and $50B2 annually)

1.8x

Increased risk of a fall when taking 10 or more medications4

(with >60% of LTC residents prescribed >= 10 medications5)

…and the Quality Score impact can be ruinous.

CAP Accredited - College of American Pathologists
CMS - Centers for Medicare & Medicaid Services

400k

Patients have benefited from Genomind’s PGx test​

850+

Organizations ordering tests monthly​

6000+

Ordering NPIs who’ve benefited from our genetic test​

20k

Medications analyzed within our reporting and software​

20+

EHR integrations, including all of the major platforms​

27

Gene panel – the most comprehensive in PGx testing​

What Our Patients and Providers Are Saying

Genomind Reveals Med Issues, Brings Hope for Schizophrenia

“I was diagnosed with schizophrenia years ago and spent years in and out of hospitals, with no hope of recovery. After my provider ordered the Genomind test, I discovered my current meds were marked as ‘high caution’ and causing many of my symptoms. Without Genomind, I would never have known what was keeping me from getting well. I am very grateful!”

Bentley
Elderly Patient

100% Satisfaction and Hope for 1,000+ Patients

“I’ve done about 1,000 patients’ genetic testing with Genomind. There’s been 100% patient satisfaction. It’s changed how patients can be part of their treatment which is integral. Not only does it give them hope they are going to get the treatment right, but it also validates their experience.”

Michele Novella
PMHNP-BC, PMHCNS-BC, APRN, Medical Director & Owner

Genetics-Based Medication Management Can Be a Powerful Tool in Case Management

Nursing homes are constantly seeking ways to optimize case management, especially for residents with chronic diseases and mental health conditions. Effective case management is crucial for improving patient outcomes, reducing healthcare costs, and empowering individuals to navigate their care.

By incorporating Genomind’s pharmacogenetic testing, nursing homes can:

Genomind’s test is a valuable addition that not only improves the care residents receive but also supports your case management team in delivering efficient, effective healthcare.

Getting Started is Simple and No-Cost

Long-term care organizations can get started in just a few simple steps. There is never any upfront cost for our providers and facilities! We handle the billing process from start to finish. Learn more about what your residents can expect.

1

Create Standing Order

Set up a standing order for your facility to streamline testing.

2

Begin Testing

Start testing residents with ease and without financial risk.

3

Improve Care

Leverage actionable insights to enhance resident care and outcomes.

Improve the Experience for Residents, Families, and Care Teams

87%

saw clinically measurable symptom improvement6

40%

fewer emergency visits7

58%

fewer hospitalizations7

~2k

estimated cost reduction per individual over 6-mo period7

Ready to Enhance Care with Genetics-Based Insights?

Use the form below to share your information or click the button to send a direct message to our LTC team. We’ll guide you through the simple, no-cost process of creating standing orders and improving care with personalized medication management.

"*" indicates required fields

Name
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.

Genomind is dedicated to safeguarding your privacy. We use the information you submit to share relevant content, products, and services. You can unsubscribe anytime. View our Privacy Policy .

Citations

  1. Taube, C., Mentzel, C., Glue, P., & Barak, Y. (2023, March 6). Aging of persons with schizophrenia: Analysis of a national dataset: International psychogeriatrics. Cambridge Core. https://www.cambridge.org/core/journals/international-psychogeriatrics/article/aging-of-persons-with-schizophrenia-analysis-of-a-national-dataset/E95FC9B108231BA625346D6FFEC5BDF6
  2. Haddad, Y. K., Bergen, G., & Florence, C. S. (2019). Estimating the economic burden related to older adult falls by State. Journal of public health management and practice : JPHMP. https://pmc.ncbi.nlm.nih.gov/articles/PMC6314899/
  3. Get the facts on falls prevention. Get the Facts on Falls Prevention. (2024, June 1). https://www.ncoa.org/article/get-the-facts-on-falls-prevention/
  4. Hood, M. K. (2018, December 3). Polypharmacy and Adverse Drug Events. ARMS. https://armspecialists.com/polypharmacy-and-adverse-drug-events/
  5. Vogel, L. (2014, June 10). Two-thirds of seniors in long-term care take 10 or more drugs: CIHI. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne. https://pmc.ncbi.nlm.nih.gov/articles/PMC4050015/
  6. Brennan FX, et al. A naturalistic study of the effectiveness of pharmacogenetic testing to guide treatment in psychiatric patients with mood and anxiety disorders. Prim Care Companion CNS Discord. 2015;17(2).doi:10.4088/PCC.14m01717
  7. Perlis RH, et al. Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study. Depression & Anxiety. 2018;35(10):946-952. doi:10.1002/da.22742